{"word_count": 117, "character_count": 886}
Auteur : Kosuke Takeuchi, Nikkei staff writerProduction : NikkeiDiffusion : site de Nikkei Asian ReviewDate : 20 août 2020Government to compensate for side effects, in bid to secure stable supplyTOKYO -- Japan's government plans to cover compensation for any health problems that may arise here from coronavirus vaccines, seeking to ensure a stable supply from foreign manufacturers as global competition intensifies, Nikkei has learned.Source : Kosuke Takeuchi, « Japan to shoulder COVID vaccine liability risks », Nikkei Asian Review, 20/08/2020. URL : https://asia.nikkei.com/Business/Pharmaceuticals/Japan-to-shoulder-COVID-vaccine-liability-risks (consulté le 20/08/2020)Photo « à la une » : Nearly 30 coronavirus vaccine candidates have entered clinical trials, according to the World Health Organization, as drugmakers compress their development timelines. (Photo by Tomoki Mera)